Return on Tangible Equity (Quarterly)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Abeona Therapeutics Inc. (ABEO) had Return on Tangible Equity of -11.78% for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$8.72M
Net Income	$-17.07M
Cost of Goods Sold	$2.70M
Gross Profit	$6.02M
Operating Expenses	$31.75M
Operating Income	$-23.03M
Non-Operating Income/Expense	$5.96M
Pre-Tax Income	$-17.07M
Normalized Pre-Tax Income	$-17.07M
Income after Taxes	$-17.07M
Income from Continuous Operations	$-17.07M
Consolidated Net Income/Loss	$-17.07M
Normalized Income after Taxes	$-17.07M
EBIT	$-23.03M
EBITDA	$-22.16M
Weighted-Average Shares Outstanding (Basic)	56.62M
Weighted-Average Shares Outstanding (Diluted)	56.62M
Earnings per Share (EPS) (Basic)	$-0.30
Earnings per Share (EPS) (Diluted)	$-0.30
Balance Sheet Financials
Current Assets	$182.99M
Property, Plant, and Equipment	$10.56M
Long-Term Assets	$15.51M
Total Assets	$198.49M
Current Liabilities	$31.05M
Long-Term Debt	$4.75M
Long-Term Liabilities	$22.51M
Total Liabilities	$53.55M
Common Equity	$144.94M
Tangible Shareholders Equity	$144.94M
Shareholders Equity	$144.94M
Common Shares Outstanding	56.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-19.80M
Cash Flow from Investing Activities	$4.96M
Cash Flow from Financial Activities	$-2.22M
Beginning Cash	$78.44M
End Cash	$61.37M
Increase/Decrease in Cash	$-17.06M
Stock-Based Compensation	$-2.43M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.12
Gross Margin	69.08%
Operating Margin	-264.14%
EBIT Margin	-264.14%
EBITDA Margin	--
Pre-Tax Profit Margin	-195.79%
Profit Margin	-195.81%
Free Cash Flow	$-20.74M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.04
Inventory Turnover	0.45
Receiveable Turnover	1.30
Days Sales in Receivables	69.24
Return on Equity	-11.78%
Return on Tangible Equity	-11.78%
Return on Assets	-8.60%
Return on Investments	-11.41%
Book Value Per Share	$2.55
Free Cash Flow per Share	$-0.37
Operating Cash Flow per Share	$-0.35

Data from Zacks Investment Research, Inc.